Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
Identifieur interne : 002883 ( Main/Exploration ); précédent : 002882; suivant : 002884Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
Auteurs : Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon StoesslSource :
- Brain [ 0006-8950 ] ; 2006-04.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- 18F-DA = 18F-fluorodopamine, 3OMFD = 3-O-methylfluorodopa, Adult, Age Factors, Age of Onset, Aged, Antiparkinson Agents (adverse effects), Antiparkinson Agents (blood), Complication, DA = dopamine, DA turnover, Dependence, Dihydroxyphenylalanine (analogs & derivatives), Dopamine Agents (adverse effects), Dopamine Agents (blood), Dyskinesia, Drug-Induced (blood), Dyskinesia, Drug-Induced (etiology), EDV = effective DA distribution volume, FD = 18F-fluorodopa, Female, Humans, Ki = FD uptake rate constant, Levodopa, Levodopa (adverse effects), Levodopa (blood), Male, Middle Aged, Nervous system diseases, PET = positron emission tomography, Parkinson Disease (blood), Parkinson Disease (diagnostic imaging), Parkinson Disease (drug therapy), ROIs = regions of interest, Tomography, Emission-Computed, Turnover, age dependence, dopaminergic system, motor complications.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Dopamine Agents, Levodopa.
- chemical , analogs & derivatives : Dihydroxyphenylalanine.
- chemical , blood : Antiparkinson Agents, Dopamine Agents, Levodopa.
- blood : Dyskinesia, Drug-Induced, Parkinson Disease.
- diagnostic imaging : Parkinson Disease.
- drug therapy : Parkinson Disease.
- etiology : Dyskinesia, Drug-Induced.
- Adult, Age Factors, Age of Onset, Aged, Female, Humans, Male, Middle Aged, Tomography, Emission-Computed.
Abstract
Treatment-related motor complications in Parkinson's disease have been previously linked to disease-induced pre-synaptic alterations: dopaminergic denervation and changes in dopamine (DA) release patterns. The occurrence of such complications is also known to be partly dependent on the age of disease onset, occurring more frequently in patients with disease onset at a younger age. Using positron emission tomography (PET) and 4-h-long 18F-fluorodopa (FD) scans we have investigated in vivo an age dependence of disease-induced changes in DA turnover as a possible contributing factor to the age-related differences in treatment-related motor complications. We evaluated the relative changes in DA turnover (measured by its direct inverse, effective DA distribution volume—EDV) and DA synthesis and vesicular storage capacity (quantified by the plasma input uptake rate constant Ki) in Parkinson's disease patients as a function of age (n = 27, age range 38–79 years). After correcting for disease severity, a significant negative correlation was found between age and magnitude of disease-induced decrease in EDV and in Ki in the putamen (P < 0.001, P = 0.02, respectively). However, the difference between the disease-induced decrease in EDV and that in Ki also exhibited an age dependence (P < 0.001), indicating a relatively higher disease-induced increase in DA turnover (inverse of EDV) compared with the decrease in DA synthesis and storage rate in patients of younger age compared with older patients. This finding implies that DA turnover in younger-onset patients undergoes a relatively greater alteration and thus likely contributes to a greater imbalance between DA synthesis, storage and release, which could lead to larger swings in synaptic DA levels. It has indeed been suggested on theoretical grounds that such imbalance may contribute to the greater propensity for motor fluctuations. These results provide one possible explanation for the age-dependent occurrence of complications and support the existence of a pre-synaptic contribution to the occurrence of motor complications.
Url:
DOI: 10.1093/brain/awl028
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002703
- to stream Istex, to step Curation: 002703
- to stream Istex, to step Checkpoint: 000C26
- to stream PubMed, to step Corpus: 001177
- to stream PubMed, to step Curation: 001177
- to stream PubMed, to step Checkpoint: 001177
- to stream Ncbi, to step Merge: 000618
- to stream Ncbi, to step Curation: 000618
- to stream Ncbi, to step Checkpoint: 000618
- to stream Main, to step Merge: 002B70
- to stream PascalFrancis, to step Corpus: 000846
- to stream PascalFrancis, to step Curation: 000477
- to stream PascalFrancis, to step Checkpoint: 000755
- to stream Main, to step Merge: 002C53
- to stream Main, to step Curation: 002883
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications</title>
<author><name sortKey="Sossi, Vesna" sort="Sossi, Vesna" uniqKey="Sossi V" first="Vesna" last="Sossi">Vesna Sossi</name>
</author>
<author><name sortKey="De La Fuente Ferna Ndez, Rau L" sort="De La Fuente Ferna Ndez, Rau L" uniqKey="De La Fuente Ferna Ndez R" first="Rau L" last="De La Fuente-Ferna Ndez">Rau L De La Fuente-Ferna Ndez</name>
</author>
<author><name sortKey="Schulzer, Michael" sort="Schulzer, Michael" uniqKey="Schulzer M" first="Michael" last="Schulzer">Michael Schulzer</name>
</author>
<author><name sortKey="Adams, John" sort="Adams, John" uniqKey="Adams J" first="John" last="Adams">John Adams</name>
</author>
<author><name sortKey="Stoessl, Jon" sort="Stoessl, Jon" uniqKey="Stoessl J" first="Jon" last="Stoessl">Jon Stoessl</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:002F98A4082AAD5FAFCC17DD395396D834365C29</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1093/brain/awl028</idno>
<idno type="url">https://api-v5.istex.fr/document/002F98A4082AAD5FAFCC17DD395396D834365C29/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002703</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002703</idno>
<idno type="wicri:Area/Istex/Curation">002703</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C26</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C26</idno>
<idno type="wicri:doubleKey">0006-8950:2006:Sossi V:age:related:differences</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16476675</idno>
<idno type="wicri:Area/PubMed/Corpus">001177</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001177</idno>
<idno type="wicri:Area/PubMed/Curation">001177</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001177</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001177</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001177</idno>
<idno type="wicri:Area/Ncbi/Merge">000618</idno>
<idno type="wicri:Area/Ncbi/Curation">000618</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000618</idno>
<idno type="wicri:Area/Main/Merge">002B70</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:06-0207424</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000846</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000477</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000755</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000755</idno>
<idno type="wicri:doubleKey">0006-8950:2006:Sossi V:age:related:differences</idno>
<idno type="wicri:Area/Main/Merge">002C53</idno>
<idno type="wicri:Area/Main/Curation">002883</idno>
<idno type="wicri:Area/Main/Exploration">002883</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications</title>
<author><name sortKey="Sossi, Vesna" sort="Sossi, Vesna" uniqKey="Sossi V" first="Vesna" last="Sossi">Vesna Sossi</name>
<affiliation></affiliation>
<affiliation><wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="De La Fuente Ferna Ndez, Rau L" sort="De La Fuente Ferna Ndez, Rau L" uniqKey="De La Fuente Ferna Ndez R" first="Rau L" last="De La Fuente-Ferna Ndez">Rau L De La Fuente-Ferna Ndez</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Division of Neurology, Hospital Arquitecto Marcide, 15405 Ferrol (A Coruña)</wicri:regionArea>
<wicri:noRegion>15405 Ferrol (A Coruña)</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Schulzer, Michael" sort="Schulzer, Michael" uniqKey="Schulzer M" first="Michael" last="Schulzer">Michael Schulzer</name>
<affiliation></affiliation>
<affiliation><wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adams, John" sort="Adams, John" uniqKey="Adams J" first="John" last="Adams">John Adams</name>
<affiliation wicri:level="1"><country>Canada</country>
<wicri:regionArea>Pacific Parkinson's Research Centre, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Stoessl, Jon" sort="Stoessl, Jon" uniqKey="Stoessl J" first="Jon" last="Stoessl">Jon Stoessl</name>
<affiliation></affiliation>
<affiliation><wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Brain</title>
<title level="j" type="abbrev">Brain</title>
<idno type="ISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="2006-04">2006-04</date>
<biblScope unit="volume">129</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="1050">1050</biblScope>
<biblScope unit="page" to="1058">1058</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>18F-DA = 18F-fluorodopamine</term>
<term>3OMFD = 3-O-methylfluorodopa</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Age of Onset</term>
<term>Aged</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (blood)</term>
<term>Complication</term>
<term>DA = dopamine</term>
<term>DA turnover</term>
<term>Dependence</term>
<term>Dihydroxyphenylalanine (analogs & derivatives)</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Dopamine Agents (blood)</term>
<term>Dyskinesia, Drug-Induced (blood)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>EDV = effective DA distribution volume</term>
<term>FD = 18F-fluorodopa</term>
<term>Female</term>
<term>Humans</term>
<term>Ki = FD uptake rate constant</term>
<term>Levodopa</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (blood)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>PET = positron emission tomography</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (diagnostic imaging)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>ROIs = regions of interest</term>
<term>Tomography, Emission-Computed</term>
<term>Turnover</term>
<term>age dependence</term>
<term>dopaminergic system</term>
<term>motor complications</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Dihydroxyphenylalanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Age of Onset</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Tomography, Emission-Computed</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Complication</term>
<term>Dépendance</term>
<term>Lévodopa</term>
<term>Système nerveux pathologie</term>
<term>Turnover</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Treatment-related motor complications in Parkinson's disease have been previously linked to disease-induced pre-synaptic alterations: dopaminergic denervation and changes in dopamine (DA) release patterns. The occurrence of such complications is also known to be partly dependent on the age of disease onset, occurring more frequently in patients with disease onset at a younger age. Using positron emission tomography (PET) and 4-h-long 18F-fluorodopa (FD) scans we have investigated in vivo an age dependence of disease-induced changes in DA turnover as a possible contributing factor to the age-related differences in treatment-related motor complications. We evaluated the relative changes in DA turnover (measured by its direct inverse, effective DA distribution volume—EDV) and DA synthesis and vesicular storage capacity (quantified by the plasma input uptake rate constant Ki) in Parkinson's disease patients as a function of age (n = 27, age range 38–79 years). After correcting for disease severity, a significant negative correlation was found between age and magnitude of disease-induced decrease in EDV and in Ki in the putamen (P < 0.001, P = 0.02, respectively). However, the difference between the disease-induced decrease in EDV and that in Ki also exhibited an age dependence (P < 0.001), indicating a relatively higher disease-induced increase in DA turnover (inverse of EDV) compared with the decrease in DA synthesis and storage rate in patients of younger age compared with older patients. This finding implies that DA turnover in younger-onset patients undergoes a relatively greater alteration and thus likely contributes to a greater imbalance between DA synthesis, storage and release, which could lead to larger swings in synaptic DA levels. It has indeed been suggested on theoretical grounds that such imbalance may contribute to the greater propensity for motor fluctuations. These results provide one possible explanation for the age-dependent occurrence of complications and support the existence of a pre-synaptic contribution to the occurrence of motor complications.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>Espagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Schulzer, Michael" sort="Schulzer, Michael" uniqKey="Schulzer M" first="Michael" last="Schulzer">Michael Schulzer</name>
<name sortKey="Sossi, Vesna" sort="Sossi, Vesna" uniqKey="Sossi V" first="Vesna" last="Sossi">Vesna Sossi</name>
<name sortKey="Stoessl, Jon" sort="Stoessl, Jon" uniqKey="Stoessl J" first="Jon" last="Stoessl">Jon Stoessl</name>
</noCountry>
<country name="Espagne"><noRegion><name sortKey="De La Fuente Ferna Ndez, Rau L" sort="De La Fuente Ferna Ndez, Rau L" uniqKey="De La Fuente Ferna Ndez R" first="Rau L" last="De La Fuente-Ferna Ndez">Rau L De La Fuente-Ferna Ndez</name>
</noRegion>
</country>
<country name="Canada"><noRegion><name sortKey="Adams, John" sort="Adams, John" uniqKey="Adams J" first="John" last="Adams">John Adams</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002883 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002883 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:002F98A4082AAD5FAFCC17DD395396D834365C29 |texte= Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications }}
This area was generated with Dilib version V0.6.29. |